期刊文献+

依托泊苷诱导骨肉瘤细胞凋亡的实验研究 被引量:5

Experimental study on apoptotic effect of etoposide on osteosarcoma cells
下载PDF
导出
摘要 目的:探讨依托泊苷对骨肉瘤细胞的毒性作用和作用机制。方法:用NTT比色法检测0.02,0.04,0.08,0.16,0.31,0.62,1.25,2.5,5.0mg·L^(-1)浓度梯度依托泊苷作用骨肉瘤细胞24,48,72和96h后的细胞活性。用流式细胞仪检测依托泊苷作用骨肉瘤细胞后细胞凋亡情况。用电镜观察药物作用后骨肉瘤细胞形态改变。结果:依托泊苷对骨肉瘤细胞有明显的生长抑制作用,随着药物浓度和作用时间的增加,细胞凋亡明显增加,依托泊苷可以诱导骨肉瘤细胞凋亡。依托泊苷作用后骨肉瘤细胞出现典型的凋亡改变,透视电镜可见细胞核仁消失,染色质浓缩聚集核膜下。结论:依托泊苷对骨肉瘤细胞有杀伤作用,细胞毒作用与促细胞凋亡有关。 AIM: To evaluate the cytotoxicity of etoposide (VP16) on the U2-OS tumor cells and its mechanism. METHODS: The activity of VP16 with different grades of concentrations to U2-OS cells after 24 h, 48 h, 72 h and 96 h culture was detected by colorimetric MTT test. U2-OS cells apoptosis caused by reaction with VP16 was observed by flow cytometry (FCM) . Transmission electron microscopy was applied to observe the morphologic changes of the bone sarcoma cells after treatment. RESULTS: VP16 inhibited the growth of osteosarcomatous cells effectively in a time-dependent manner and dose-dependent manner with obvious increase of cell apoptosis, probably due to inducement. Transmission electron microscopy showed disappearance of nucleol and condensation of chromatin under the nucleonic membrane, and the typical morphologic apoptotic changes were not found in the control group. CONCLUSION: Etoposide can induce apoptosis of the U2-OS tumor cells with relation to the cytotoxicity and damage on osteosarcomateous cells.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第9期718-721,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 依托泊苷 骨肉瘤 细胞凋亡 etoposide osteosarcoma apoptosis
  • 相关文献

参考文献8

  • 1BRAMWELL VH. The role of chemotherapy in tile management of non-metastatic operable extremity osteosarcoma [J]. Semin Oncol, 1997,24(5 ) :561-571.
  • 2ROSEN G, CAPARROS B, HUVOS AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of primary tumor to preoperative chemotherapy[J]. Cancer, 1982, 49 (6): 1221 -1230.
  • 3ROSEN G. An opinion supporting the role of high-dosemethotrexate in the treatment of osteosarcoma[J]. Cancer Treat Res, 1993,62:49-54.
  • 4SALCH RA, GRAHAM-POLE J, CASSANO WF, et al. Response of osteogenie sarcoma to the combination of etoposide and eyeloptlosphamide as neoaduvant etlemotherapy[J]. Cancer, 1990,65(4) :861-865.
  • 5刘春选,戴刚,张祥生,王秉义.人骨肉瘤细胞MTT法药敏试验及应用[J].中华骨科杂志,1997,17(12):754-756. 被引量:7
  • 6张哑历,姜泊,周殿元.分子生物学常用实验方法[M].北京:人民军医出版社,1996:170—183.
  • 7李莉,孔宪涛.细胞凋亡检测方法评价[J].上海医学检验杂志,2000,15(1):57-59. 被引量:16
  • 8王巍.药品行政保护品种介绍:抗肿瘤药(一)(待续)[J].中国新药与临床杂志,2003,22(5):317-318. 被引量:4

二级参考文献4

  • 1唐鸣镝.国内旅游小城镇景观建设探析[J].北京第二外国语学院学报,2007,29(1):28-32. 被引量:18
  • 2刘晓东,实用肿瘤学杂志,1992年,7卷,39页
  • 3王顺宝,实用肿瘤学杂志,1992年,7卷,8页
  • 4贾床瑞,肿瘤防治研究,1992年,19卷,163页

共引文献24

同被引文献34

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部